Quantcast
Connect with us

Catalyst Pharmaceuticals defends $375,000 drug price after Bernie Sanders rebuke

Published

on

Catalyst Pharmaceuticals Inc, rebuked by U.S. Senator Bernie Sanders for its high drug prices, on Thursday defended its $375,000 treatment for a rare disease, saying the price was in line with similar products in the industry.

Sanders, a vocal critic of high drug prices, had written to Florida-based Catalyst earlier this month, asking it to justify its price for Firdapse, a medication for a rare neuromuscular disease that affects about one in 100,000 people in the United States.

ADVERTISEMENT

Drug pricing has been a major talking point in the United States for the past few years. It was also one of the campaign promises made by President Donald Trump in the 2016 elections, but so far the debate has not resulted in lowering healthcare costs for Americans.

The Trump administration last month proposed a rule to overhaul the industry’s system of rebates, or discounts, while Sanders last month unveiled legislation aimed at lowering drug prices.

For years, patients were able to get Firdapse for free from Jacobus Pharmaceuticals, a small New Jersey-based drug company that offered the drug through a U.S. Food and Drug Administration (FDA) program called “compassionate use.”

The program allows patients with rare diseases and conditions access to drugs not yet approved outside of a clinical trial, when there is no viable alternative.

ADVERTISEMENT

Catalyst bought the U.S. rights to the drug in 2012 and got approval to sell it in the United States in November last year.

The company said, before its November approval, only about 200 of an estimated 3,000 Lambert-Eaton Myasthenic Syndrome (LEMS) patients in the United States received some form of Firdapse, pointing to a large unmet medical need.

ADVERTISEMENT

“Now, for the first time, LEMS patients have confidence their therapy is FDA approved and is safe and effective,” Catalyst’s Chief Executive Officer Patrick McEnany said in a letter.

The office of Bernie Sanders, who is seeking the Democratic Party’s presidential nomination in 2020, was not immediately available for comment.

The company said that Firdapse’s price was similar to other products that provide a significant clinical benefit in treating ultra-rare diseases, adding it believed the drug would be widely reimbursed by insurers for the small population it treats.

ADVERTISEMENT

Physicians can write a prescription where Firdapse will be delivered to a patient’s door and in most cases at an out-of-pocket cost of less than $10 per month, Catalyst said.

Reporting by Manas Mishra and Aakash Jagadeesh Babu in Bengaluru; Editing by Arun Koyyur and Sweta Singh

Enjoy this piece?

… then let us make a small request. Like you, we here at Raw Story believe in the power of progressive journalism — and we’re investing in investigative reporting as other publications give it the ax. Raw Story readers power David Cay Johnston’s DCReport, which we've expanded to keep watch in Washington. We’ve exposed billionaire tax evasion and uncovered White House efforts to poison our water. We’ve revealed financial scams that prey on veterans, and legal efforts to harm workers exploited by abusive bosses. We’ve launched a weekly podcast, “We’ve Got Issues,” focused on issues, not tweets. And unlike other news outlets, we’ve decided to make our original content free. But we need your support to do what we do.

Raw Story is independent. You won’t find mainstream media bias here. We’re not part of a conglomerate, or a project of venture capital bros. From unflinching coverage of racism, to revealing efforts to erode our rights, Raw Story will continue to expose hypocrisy and harm. Unhinged from billionaires and corporate overlords, we fight to ensure no one is forgotten.

We need your support to keep producing quality journalism and deepen our investigative reporting. Every reader contribution, whatever the amount, makes a tremendous difference. Invest with us in the future. Make a one-time contribution to Raw Story Investigates, or click here to become a subscriber. Thank you. Click to donate by check.

Enjoy this piece?

… then let us make a small request. Like you, we here at Raw Story believe in the power of progressive journalism — and we’re investing in investigative reporting as other publications give it the ax. Raw Story readers power David Cay Johnston’s DCReport, which we've expanded to keep watch in Washington. We’ve exposed billionaire tax evasion and uncovered White House efforts to poison our water. We’ve revealed financial scams that prey on veterans, and efforts to harm workers exploited by abusive bosses. We’ve launched a weekly podcast, “We’ve Got Issues,” focused on issues, not tweets. Unlike other news sites, we’ve decided to make our original content free. But we need your support to do what we do.

Raw Story is independent. You won’t find mainstream media bias here. We’re not part of a conglomerate, or a project of venture capital bros. From unflinching coverage of racism, to revealing efforts to erode our rights, Raw Story will continue to expose hypocrisy and harm. Unhinged from corporate overlords, we fight to ensure no one is forgotten.

We need your support to keep producing quality journalism and deepen our investigative reporting. Every reader contribution, whatever the amount, makes a tremendous difference. Invest with us in the future. Make a one-time contribution to Raw Story Investigates, or click here to become a subscriber. Thank you.



Report typos and corrections to: [email protected]. Send news tips to: [email protected].
READ COMMENTS - JOIN THE DISCUSSION
Continue Reading

Breaking Banner

Trump Twitter-rages at ‘evil propaganda machine’ New York Times

Published

on

President Donald Trump kicked off his Sunday morning by going on a multi-tweet rant about the New York Times where he blamed them for his poor poll numbers and called them "an evil propaganda machine.'

Trump began with, "The Failing New York Times, in one of the most devastating portrayals of bad journalism in history, got caught by a leaker that they are shifting from their Phony Russian Collusion Narrative (the Mueller Report & his testimony were a total disaster), to a Racism Witch Hunt....., " before adding, "'Journalism' has reached a new low in the history of our Country. It is nothing more than an evil propaganda machine for the Democrat Party. The reporting is so false, biased and evil that it has now become a very sick joke...But the public is aware! #CROOKEDJOURNALISM."

Continue Reading

Breaking Banner

Trump suggests hitting France with 100 percent tariff on wine over dispute with Macron

Published

on

According to a report from Bloomberg, President Donald Trump publicly suggested that he would consider a 100 percent tariff on wines coming from France.

The report states that the president recently made the suggestion as part of his trade war that has crippled American manufacturers and farmers while at the same time hitting American consumers' wallets.

Trump's comments came during a recent Long Island fundraiser and were tied to his unhappiness with President Emmanuel Macron and his tax on multinational technology companies.

Continue Reading
 

Breaking Banner

Gun found in FedEx package sent from US to China

Published

on

Chinese authorities have found at least one firearm in a FedEx package sent from the US, local police said Sunday, in the latest incident to befall the logistics firm in China.

Police in Fuzhou, eastern Fujian province, said "in recent days" they had received a tip about a package sent to a Fujian-based sporting goods company.

The parcel was sent by a US client and contained at least one firearm, said Jin'an district police through their official Twitter-like Weibo account.

The firearm has been seized and officers are investigating, they added, without specifying the number of weapons in the package.

Continue Reading
 
 

Thank you for whitelisting Raw Story!

As a special thank you, from now until August 31st, we're offering you a discounted rate of $5.99/month to subscribe and get ad-free access. We're honored to have you as a reader. Thank you. :) —Elias, Membership Coordinator
LEARN MORE
close-link
close-image